Analysis of adverse events attribution and reporting in cancer clinical trials: A systematic review ScienceDirect In 2023, the FDA banned 19 peptides from compounding pharmacies. No specific safety incident. No clear signal. Just a regulatory decision that pushed millions of patients toward gray market suppliers and overseas Adverse Event Reporting in Clinical Trials Population Scale Identification of Differential Adverse Events Before and During a Pandemic Zitnik Lab Documenting Adverse Events Applied Clinical Trials Online An Evaluation Benchmark for Adverse Drug Event Prediction from Clinical Trial Results Scientific Data